|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ARTICLES
1Department of Physiology, University of Tübingen, Tübingen, Germany; and 2Department of Biology, Chemistry, and Pharmacy, Free University Berlin, Germany
Submitted 2 February 2009 ; accepted in final form 1 June 2009
Adenomatous polyposis coli (APC) fosters degradation of β-catenin, a multifunctional protein upregulating the serum- and glucocorticoid-inducible kinase (SGK1). SGK1 regulates a wide variety of renal transport processes. The present study explored the possibility that APC influences renal function. To this end, metabolic cage experiments were performed in mice carrying a loss-of-function mutation in the APC gene (apcMin/+), their wild-type littermates (apc+/+), and apcMin/+ mice lacking functional SGK1 (apcMin/+/sgk1–/–). As a result, mean body weight, food intake, fluid intake, salt appetite, urinary flow, as well as plasma Na+ and K+ concentrations were similar in apcMin/+ mice, apc+/+ mice, and apcMin/+/sgk1–/– mice. Glomerular filtration rate and absolute renal Na+ excretion were decreased, and fractional urinary K+ excretion was enhanced in apcMin/+ mice. The antinatriuresis, but not the hypofiltration and kaliuresis was partially reversed by additional lack of SGK1. Plasma corticosterone and aldosterone concentrations were significantly enhanced in apcMin/+ mice. While the plasma corticosterone concentration was similar in apc+/+ mice and apcMin/+/sgk1–/– mice, plasma aldosterone was even higher in apcMin/+/sgk1–/– mice than in apcMin/+ mice. The hyperaldosteronism of apcMin/+ mice was paralleled by significantly elevated plasma volume and blood pressure. The experiments reveal an influence of defective APC on adrenal hormone release and renal function, effects partially but not completely explained by APC dependence of SGK1 expression.
adenomatous polyposis coli; serum and glucocorticoid inducible kinase; aldosterone; corticosterone
This article has been cited by other articles:
![]() |
A. Just Going with the Wnt? Focus on "Hyperaldosteronism, hypervolemia, and increased blood pressure in mice expressing defective APC" Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2009; 297(3): R568 - R570. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |